Rankings
▼
Calendar
DBVT Q3 2024 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena
DBVT
DBV Technologies S.A.
$560M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
$1M
100.0% margin
Operating Income
-$30M
-2829.1% margin
Net Income
-$30M
-2839.7% margin
EPS (Diluted)
$-1.60
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$93M
Total Liabilities
$39M
Stockholders' Equity
$54M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$0
—
Gross Profit
$1M
-$455,635
+335.3%
Operating Income
-$30M
-$21M
-47.7%
Net Income
-$30M
-$17M
-82.8%
← FY 2024
All Quarters
Q4 2024 →